Nexentis Technologies (NXTS) Stock News
$NXTS · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Nexentis Technologies (NXTS) in the past 30 days. BORSA’s news read on NXTS is leaning bullish at 54/100, unchanged over 24 hours, based on 1 company event over the past 30 days. Nexentis Technologies’ next earnings report is scheduled for Thursday, Nov 12.
The wire on $NXTS
newest first · updated · direct subject stories onlyNexentis Technologies (NXTS) said its subsidiary MitoCareX Bio has moved its computational drug discovery platform to Google Cloud, aiming to improve capacity, data governance, and operational flexibility.
neutral 50 · impact 20